Recently, Sai Wei Electronics said on the interactive platform that the company's Swedish factory has indeed been in a state of tight production capacity, and the upgrading and expansion of the production line this year can be alleviated in the short term, but in the long run, there is still a need to further expand production capacity. Swedish factories will consider and make decisions according to the specific conditions of production and the specific needs of customers.
Saiwei Electronics further explained that for the company's Swedish subsidiary Silex, which is located in the industrial zone on the northwest outskirts of Stockholm, the company has maintained close communication with the subsidiary since the outbreak of novel coronavirus's epidemic. Silex has been taking measures such as workplace disinfection, reducing meetings and business trips, strict monitoring, and increasing critical inventory to carry out active prevention and control, because chip manufacturing itself requires an ultra-clean working environment. Objectively, it is also conducive to the prevention and control of the epidemic situation by subsidiaries. The latest number of employees of Silex in Sweden is 292. at present, 2 employees have symptoms of novel coronavirus infection. since the outbreak of the novel coronavirus epidemic at the beginning of the year, there have been a total of 10 cases. the practice of Swedish subsidiaries is to arrange employees with infection symptoms to return home for rest and observation, disappear their symptoms, recover their health, and then return to work at the company. so far, there has been no more serious situation, and the epidemic has occurred for nearly a year. The management team of the Swedish subsidiary has a stable mentality and believes that the factory can continue to do good prevention and control, so Swedish SIlex has always maintained and is confident that it will continue to operate normally and continue to work hard to meet the strong MEMS OEM needs of downstream customers.
Silex, a subsidiary of the company, signed an order with a biomedical strategic customer An in the range of 15.456 million-34.776 million euros during the execution period from 2021 to 2022, accounting for 17% of the company's total revenue in 2019, according to the company's official Weibo account. Strategic customers in the biomedical field have made an advance payment of 6.5 million euros and the rest will be paid on the basis of batch delivery of products and services.
Silex of Sweden established a close strategic partnership with Company An at the beginning of its establishment, and has been providing professional MEMS chip process development and wafer manufacturing services for Company A. with the continuous maturity and iteration of the core MEMS chip technology, the terminal products of Company An also continue to improve their technical performance, improve the ease of use of technology, and expand the field of technology application. Over the past decade or so, the amount of cooperation between the two sides has increased from hundreds of thousands of yuan to tens of millions of yuan, showing an exponential growth trend. The signing of this order indicates that the third-generation DNA/RNA sequencing equipment of Company A has entered the stage of mature production.
![[SMM Analysis] Stainless Steel Social Inventory Saw a Slight Buildup, While High Supply Coupled with Cautious Downstream Demand Constrained Destocking](https://imgqn.smm.cn/usercenter/bFzkj20251217171724.jpg)
